Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates
- PMID: 3516876
- PMCID: PMC261031
- DOI: 10.1128/iai.52.2.519-528.1986
Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates
Abstract
Covalent binding to immunogenic proteins increases the immunogenicity of the capsular polysaccharides of Haemophilus influenzae type b (Hib) and pneumococcus type 6A (Pn6A). Conjugates composed of Hib, Pn6A, or the cross-reacting Escherichia coli K100 covalently bound to tetanus toxoid (TT) were injected into young adult volunteers. Local reactions were common and were probably due to Arthus reactivity mediated by the preexisting antibodies reacting with the TT component of the conjugates. Fever occurred in about 10% of the volunteers after the first injection; no volunteers had fever after the second injection. Similar levels of Hib or Pn6A antibodies were elicited by either 50- or 100-micrograms doses or by concurrent injection of two different conjugates (Hib-TT and Pn6A-TT or Hib-TT and K100-TT). The Hib-TT elicited about a 180-fold increase in Hib antibodies, and the Pn6A-TT conjugate elicited about an 8-fold increase in Pn6A antibodies after one injection. Booster reactions were not elicited in adults; similar levels of antibodies in the five experimental groups suggested that the responses elicited by the conjugates were maximal. A one-way cross-reaction was noted as Pn6A conjugates elicited rises of Hib antibodies in 13 of 20 volunteers; only 4 of 59 volunteers immunized with Hib-TT had increases in Pn6A antibodies. The preimmunization Hib antibodies were composed of immunoglobulin M (IgM), IgA, and IgG. The postimmunization sera showed an increase in all three isotypes; the elevation of the IgG was the highest of the three isotypes. Conjugate-induced antibodies to both the polysaccharide and TT exerted biological activities that have been correlated with immunity. Adsorption of the Hib-TT onto aluminium hydroxide resulted in higher levels and an earlier Hib antibody response in infant rhesus. These results encourage the evaluation of Hib and Pn6A conjugates in human children and infants.
Similar articles
-
Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates.Infect Immun. 1983 Apr;40(1):245-56. doi: 10.1128/iai.40.1.245-256.1983. Infect Immun. 1983. PMID: 6601061 Free PMC article.
-
Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates.Infect Immun. 1984 Sep;45(3):582-91. doi: 10.1128/iai.45.3.582-591.1984. Infect Immun. 1984. PMID: 6332076 Free PMC article.
-
Studies on Pneumococcus vaccine alone or mixed with DTP and on Pneumococcus type 6B and Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugates in two- to five-year-old children with sickle cell anemia.Pediatr Infect Dis J. 1990 Mar;9(3):181-6. doi: 10.1097/00006454-199003000-00007. Pediatr Infect Dis J. 1990. PMID: 2336298
-
Haemophilus influenzae type b: the search for a vaccine.Pediatr Infect Dis J. 1987 Aug;6(8):791-4. doi: 10.1097/00006454-198708000-00039. Pediatr Infect Dis J. 1987. PMID: 3313243 Review.
-
MenHibrix: a new combination meningococcal vaccine for infants and toddlers.Ann Pharmacother. 2014 Mar;48(3):404-11. doi: 10.1177/1060028013514375. Epub 2013 Dec 18. Ann Pharmacother. 2014. PMID: 24353263 Review.
Cited by
-
Carriers and Antigens: New Developments in Glycoconjugate Vaccines.Vaccines (Basel). 2023 Jan 19;11(2):219. doi: 10.3390/vaccines11020219. Vaccines (Basel). 2023. PMID: 36851097 Free PMC article. Review.
-
Induction of Susceptibility to Disseminated Infection with IgA1 Protease-Producing Encapsulated Pathogens Streptococcus pneumoniae, Haemophilus influenzae Type b, and Neisseria meningitidis.mBio. 2022 Jun 28;13(3):e0055022. doi: 10.1128/mbio.00550-22. Epub 2022 Apr 14. mBio. 2022. PMID: 35420467 Free PMC article.
-
Chemically Modified Bacterial Sacculi as a Vaccine Microparticle Scaffold.ACS Chem Biol. 2022 May 20;17(5):1184-1196. doi: 10.1021/acschembio.2c00140. Epub 2022 Apr 12. ACS Chem Biol. 2022. PMID: 35412807 Free PMC article.
-
Assessment of the impact of manufacturing changes on the physicochemical properties of the recombinant vaccine carrier ExoProtein A.Vaccine. 2019 Sep 10;37(38):5762-5769. doi: 10.1016/j.vaccine.2018.09.037. Epub 2018 Sep 24. Vaccine. 2019. PMID: 30262247 Free PMC article.
-
Protein carriers of conjugate vaccines: characteristics, development, and clinical trials.Hum Vaccin Immunother. 2013 Dec;9(12):2505-23. doi: 10.4161/hv.26109. Epub 2013 Aug 16. Hum Vaccin Immunother. 2013. PMID: 23955057 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous